Details of the Drug
General Information of Drug (ID: DM8EZYM)
| Drug Name |
Etozolin
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
Etozolin; Etozoline; Elkapin; Etozolin [USAN:INN]; Etozoline [INN-French]; Etozolinum [INN-Latin]; Etozolino [INN-Spanish]; EINECS 200-794-0; GO 687; W2900A; NSC 310039; W 2900 A; 67432-21-7; 2-Carbethoxymethylene-3-methyl-5-piperidino-4-thiazolidone; 3-Methyl-4-oxo-5-piperidino-delta(sup2, alpha)thiazolidineacetic; Ethyl (Z)-(3-methyl-4-oxo-5-piperidino-thiazolidin-2-ylidene)acetate; 3-Methyl-4-oxo-5-piperidino-delta(sup 2,a)-thiazolidineacetic acid ethyl ester
|
||||||||||||||||||
| Indication |
|
||||||||||||||||||
| ATC Code | |||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
| Drug ADMET Endpoint Profile (DAE)NEW | Click to Jump to the Detailed DAE Information of This Drug | ||||||||||||||||||

